Genocea finds new malaria biomarker

Genocea Profiles T cell Responses to Identify Antigens Associated with Malaria Episodes Findings reveal evidence of malaria in immune system years after clinical episodes November 5, 2014 Genocea Biosciences, Inc., a company developing T cell-directed vaccines and immunotherapies, today presented study results identifying a cluster of antigens that may be a biomarker of disease. The findings, generated using Genocea‚Äôs proprietary …